rAAV2tYF-GRK1-hRPGRco clinical trials

A Clinical Trial Evaluating the Safety and Efficacy of a Single Subretinal Injection of AGTC-501 in Participants With XLRP

This study checks a new gene therapy, AGTC-501, for young men with an eye condition called X-linked retinitis pigmentosa (XLRP). It aims to see if it's safe and helps improve their eyesight, comparing two doses to an untreated group.